Correlation Between CLPS and Lixte Biotechnology

Can any of the company-specific risk be diversified away by investing in both CLPS and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CLPS and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CLPS Inc and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on CLPS and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CLPS with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of CLPS and Lixte Biotechnology.

Diversification Opportunities for CLPS and Lixte Biotechnology

-0.03

Correlation Coefficient

CLPS  Lixte Biotechnology

Good diversification

The 3 months correlation between CLPS and Lixte is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding CLPS Inc and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and CLPS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CLPS Inc are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of CLPS i.e., CLPS and Lixte Biotechnology go up and down completely randomly.

Pair Corralation between CLPS and Lixte Biotechnology

Given the investment horizon of 90 days CLPS Inc is expected to generate 0.5 times more return on investment than Lixte Biotechnology. However, CLPS Inc is 2.01 times less risky than Lixte Biotechnology. It trades about 0.04 of its potential returns per unit of risk. Lixte Biotechnology Holdings is currently generating about -0.09 per unit of risk. If you would invest  113.00  in CLPS Inc on December 27, 2024 and sell it today you would earn a total of  5.00  from holding CLPS Inc or generate 4.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CLPS Inc  vs.  Lixte Biotechnology Holdings

CLPS Inc

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in CLPS Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, CLPS may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Lixte Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lixte Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with CLPS and Lixte Biotechnology

The main advantage of trading using opposite CLPS and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CLPS position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.

The idea behind CLPS Inc and Lixte Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.